You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
15 October 2026 - Clinical-stage biotechnology company Continuity Biosciences LLC announced on Wednesday that it has been awarded a grant of up to USD9.6m from the Gates Foundation to advance a subcutaneous, ultra-long-acting antiretroviral (ARV) imp...
15 October 2026 - Clinical-stage biopharmaceutical company Viking Therapeutics Inc (NASDAQ:VKTX) announced on Wednesday the initiation of the SUNRISE Phase 3 clinical programme for oral VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) an...
14 October 2026 - Biopharmaceutical company Pharming Group N.V. (Euronext Amsterdam:PHARM) (NASDAQ:PHAR) on Wednesday reported positive topline Phase II trial results for leniolisib in genetically identifiable primary immunodeficiencies (PIDs) with i...
14 October 2026 - Radiopharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) announced on Wednesday that it will present 20 company-related abstracts at the 39th European Association of Nuclear Medicine (EANM) Annual Congress i...
14 October 2026 - CTC intelligence company CelLBxHealth plc (AIM: CLBX) reported on Wednesday that it has signed a new Statement of Work (SOW) worth approximately USD65,000 under an existing Master Services Agreement with a US-based pharmaceutical co...
14 October 2026 - Medical technology company Vantis Vascular announced on Tuesday that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for a new 6 French (6F) model of its CrossFAST Integrated Microcatheter Advanced De...
13 October 2026 - Racura Oncology Limited (ASX:RAC), a late clinical-stage biopharmaceutical company, announced on Monday that the Safety Review Committee (SRC) for the Phase 1 HARNESS-1 trial has approved its lead oncology drug, RC220, to proceed to...